PTPRD encodes a transmembrane protein tyrosine phosphatase that acts as a tumor suppressor by dephosphorylating the oncoprotein STAT3. PTPRD mutations have not been reported previously in osteosarcoma or other bone tumors. The gene discussed is STAT3; the disease is neoplasm.